New MDA Program for Gene Therapy Development in Ultra-Rare Diseases: Sharon Hesterlee, PhDMarch 24th 2023
At the 2023 MDA Conference, the executive vice president and chief research officer of MDA talked about a new program from the MDA to tackle ultra-rare neuromuscular diseases. [WATCH TIME: 5 minutes]
The Expectations for the 2023 MDA Conference: Donald S. Wood, PhD; Sharon Hesterlee, PhDDecember 1st 2022
The president and CEO, as well as the executive vice president and chief research officer, of MDA, together offered an in-depth overview of what to expect from the 2023 MDA Conference, which will be held from March 19-22, 2023, in Dallas, Texas. [WATCH TIME: 12 minutes]
COVID-19 and Muscular Dystrophies, and R&D for Rare Disorders: Sharon Hesterlee, PhDMarch 16th 2021
The executive vice president and chief research officer of the MDA offered her perspective on the ongoing conversations about and impact of the pandemic on the care of patients with muscular dystrophies.
Muscular Dystrophy Association Virtual Conference to Feature Latest Advances in Neuromuscular Therapy and Clinical CareMarch 13th 2021
Sharon Hesterlee, PhD, executive vice president and chief research officer, MDA, shares an early look at the MDA's 2021 Virtual Clincial and Scientific Conference, March 15-18.
Sharon Hesterlee, PhD: How the New MOVR Data Platform Benefits Doctors and PatientsNovember 12th 2020
The executive VP and chief research officer of MDA spoke about how the new visualization reporting platform will also allow for easy recruitment of data to be used in future clinical trials and research studies.
2 Clarke Drive
Cranbury, NJ 08512